DK1492513T3 - HFA-suspensionsformuleringer indeholdende et anticholinergikum - Google Patents

HFA-suspensionsformuleringer indeholdende et anticholinergikum

Info

Publication number: DK1492513T3
Authority: DK; Denmark
Prior art keywords: anticholinergic; formulations containing; suspension formulations; hfa suspension; hfa
Prior art date: 2002-03-28

Application number

DK03745193T

Other languages

Danish (da)

English (en)

Inventor

Christel Schmelzer

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-28

Filing date

2003-03-20

Publication date

2006-12-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1492513(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-20 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2006-12-18 Application granted granted Critical

2006-12-18 Publication of DK1492513T3 publication Critical patent/DK1492513T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK03745193T 2002-03-28 2003-03-20 HFA-suspensionsformuleringer indeholdende et anticholinergikum DK1492513T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10214263A DE10214263A1 (de)	2002-03-28	2002-03-28	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum

Publications (1)

Publication Number	Publication Date
DK1492513T3 true DK1492513T3 (da)	2006-12-18

Family

ID=28050989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03745193T DK1492513T3 (da)	2002-03-28	2003-03-20	HFA-suspensionsformuleringer indeholdende et anticholinergikum

Country Status (26)

Country	Link
EP (2)	EP1492513B1 (fr)
JP (1)	JP4480401B2 (fr)
KR (1)	KR101066801B1 (fr)
CN (1)	CN1329023C (fr)
AT (1)	ATE339953T1 (fr)
AU (1)	AU2003209743B2 (fr)
BR (1)	BR0308764A (fr)
CA (1)	CA2479640C (fr)
CY (1)	CY1105543T1 (fr)
DE (2)	DE10214263A1 (fr)
DK (1)	DK1492513T3 (fr)
EA (1)	EA007239B1 (fr)
EC (1)	ECSP045321A (fr)
ES (1)	ES2273020T3 (fr)
HR (1)	HRP20040889B1 (fr)
IL (2)	IL163697A0 (fr)
ME (1)	ME00247B (fr)
MX (1)	MXPA04009337A (fr)
NO (1)	NO20044005L (fr)
NZ (1)	NZ536043A (fr)
PL (1)	PL371296A1 (fr)
PT (1)	PT1492513E (fr)
RS (1)	RS52178B (fr)
UA (1)	UA78557C2 (fr)
WO (1)	WO2003082252A1 (fr)
ZA (1)	ZA200405638B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1809243B2 (fr) †	2004-07-02	2022-06-08	Boehringer Ingelheim International GmbH	Formulations de suspensions aerosol contenant tg 227 ea en tant qu'agent propulseur
TWI396541B (zh) *	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
GB201200504D0 (en) *	2011-12-19	2012-02-22	Teva Branded Pharmaceutical Prod R & D Inc	An inhaler
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
EP2705838A1 (fr) *	2012-09-06	2014-03-12	Xspray Microparticles Ab	Préparations de tiotropium
JP2016503390A (ja) *	2012-10-23	2016-02-04	シプラ・リミテッド	医薬組成物
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
CN107056629B (zh) *	2017-04-27	2019-04-30	河北科技大学	一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5610163A (en) *	1989-09-16	1997-03-11	Boehringer Ingelheim Gmbh	Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) *	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
EP1102579B1 (fr) *	1998-08-04	2003-03-19	Jago Research Ag	Formulations d'aerosol a usage medical
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) *	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Medicaments
ES2228965T3 (es) *	2000-10-12	2005-04-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Monohidrato cristalino de bromuro de tiotropio, procedimiento para su preparacion y su uso para la produccion de un medicamento.
AU2002210575A1 (en) *	2000-10-31	2002-05-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel medicament compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

2002
- 2002-03-28 DE DE10214263A patent/DE10214263A1/de not_active Withdrawn
2003
- 2003-03-20 IL IL16369703A patent/IL163697A0/xx active IP Right Grant
- 2003-03-20 DE DE50305118T patent/DE50305118D1/de not_active Expired - Lifetime
- 2003-03-20 NZ NZ536043A patent/NZ536043A/en not_active IP Right Cessation
- 2003-03-20 UA UA20041008770A patent/UA78557C2/uk unknown
- 2003-03-20 EP EP03745193A patent/EP1492513B1/fr not_active Expired - Lifetime
- 2003-03-20 AU AU2003209743A patent/AU2003209743B2/en not_active Ceased
- 2003-03-20 EP EP06115508.1A patent/EP1695701B1/fr not_active Expired - Lifetime
- 2003-03-20 AT AT03745193T patent/ATE339953T1/de active
- 2003-03-20 MX MXPA04009337A patent/MXPA04009337A/es active IP Right Grant
- 2003-03-20 BR BR0308764-6A patent/BR0308764A/pt not_active IP Right Cessation
- 2003-03-20 EA EA200401190A patent/EA007239B1/ru not_active IP Right Cessation
- 2003-03-20 RS YU85904A patent/RS52178B/sr unknown
- 2003-03-20 ME MEP-2008-474A patent/ME00247B/fr unknown
- 2003-03-20 CN CNB038072491A patent/CN1329023C/zh not_active Expired - Lifetime
- 2003-03-20 PT PT03745193T patent/PT1492513E/pt unknown
- 2003-03-20 WO PCT/EP2003/002898 patent/WO2003082252A1/fr not_active Ceased
- 2003-03-20 HR HRP20040889AA patent/HRP20040889B1/hr not_active IP Right Cessation
- 2003-03-20 JP JP2003579790A patent/JP4480401B2/ja not_active Expired - Lifetime
- 2003-03-20 CA CA2479640A patent/CA2479640C/fr not_active Expired - Fee Related
- 2003-03-20 PL PL03371296A patent/PL371296A1/xx unknown
- 2003-03-20 KR KR1020047015356A patent/KR101066801B1/ko not_active Expired - Fee Related
- 2003-03-20 ES ES03745193T patent/ES2273020T3/es not_active Expired - Lifetime
- 2003-03-20 DK DK03745193T patent/DK1492513T3/da active
2004
- 2004-07-15 ZA ZA2004/05638A patent/ZA200405638B/en unknown
- 2004-08-24 IL IL163697A patent/IL163697A/en unknown
- 2004-09-23 NO NO20044005A patent/NO20044005L/no not_active Application Discontinuation
- 2004-09-28 EC EC2004005321A patent/ECSP045321A/es unknown
2006
- 2006-09-26 CY CY20061101380T patent/CY1105543T1/el unknown

Also Published As

Publication number	Publication date
CN1329023C (zh)	2007-08-01
CY1105543T1 (el)	2010-07-28
EP1695701B1 (fr)	2015-01-07
EA200401190A1 (ru)	2005-04-28
PT1492513E (pt)	2006-12-29
DE10214263A1 (de)	2003-10-16
CN1642534A (zh)	2005-07-20
HK1079091A1 (en)	2006-03-31
UA78557C2 (en)	2007-04-10
EA007239B1 (ru)	2006-08-25
ME00247B (fr)	2011-05-10
ZA200405638B (en)	2005-07-27
IL163697A0 (en)	2005-12-18
AU2003209743B2 (en)	2008-03-06
ECSP045321A (es)	2005-01-28
EP1492513B1 (fr)	2006-09-20
WO2003082252A1 (fr)	2003-10-09
IL163697A (en)	2011-03-31
HRP20040889B1 (hr)	2012-11-30
ES2273020T3 (es)	2007-05-01
KR20040098031A (ko)	2004-11-18
MEP47408A (en)	2011-02-10
EP1695701A3 (fr)	2010-04-28
CA2479640A1 (fr)	2003-10-09
ATE339953T1 (de)	2006-10-15
NO20044005L (no)	2004-10-05
NZ536043A (en)	2005-09-30
AU2003209743A1 (en)	2003-10-13
DE50305118D1 (de)	2006-11-02
MXPA04009337A (es)	2005-01-25
EP1492513A1 (fr)	2005-01-05
YU85904A (sh)	2006-08-17
BR0308764A (pt)	2005-01-11
JP4480401B2 (ja)	2010-06-16
EP1695701A2 (fr)	2006-08-30
KR101066801B1 (ko)	2011-09-22
CA2479640C (fr)	2010-09-28
PL371296A1 (en)	2005-06-13
RS52178B (sr)	2012-10-31
HRP20040889A2 (en)	2004-12-31
JP2005529087A (ja)	2005-09-29

Publication	Publication Date	Title
DE60315460D1 (de)	2007-09-20	Einführungshülse
IS7653A (is)	2005-01-19	MCHIR mótlyf
DE60238478D1 (de)	2011-01-13	Eren
FI20020057L (fi)	2003-07-12	Verkkovierailun järjestäminen
ATE409447T1 (de)	2008-10-15	Bequem windel
DK1670472T3 (da)	2008-04-21	Aerosolformulering til inhalation indeholdende et antikolinergikum
DE60312863D1 (de)	2007-05-10	Fahrgestell
DK1572229T3 (da)	2014-06-23	Stabilt terapeutisk fibrinogen
IS8309A (is)	2006-02-17	Lyfjablöndur
DE60310413D1 (de)	2007-01-25	Luftfederbalg
NO20034824D0 (no)	2003-10-29	Cepham-forbindelser
DE50212108D1 (de)	2008-05-29	Substituierte fluoralkoxyphenylsulfonylharnstoffe
DE60216563D1 (de)	2007-01-18	Führungsdraht
DE60236403D1 (de)	2010-07-01	Tourbillonmechanismus
DK1492513T3 (da)	2006-12-18	HFA-suspensionsformuleringer indeholdende et anticholinergikum
DE50307217D1 (de)	2007-06-21	Glaskörper
EP1384783A4 (fr)	2005-04-20	Nouveau maxizyme
NO20023047D0 (no)	2002-06-21	Kompenseringsanordning
NO20026138L (no)	2003-02-21	Stabilisator for radiofarmasöytiske midler
NO20024880L (no)	2003-09-22	Sammensetning inneholdende fosfat
ITMI20031187A0 (it)	2003-06-12	Astuccio per occhiali
DE60237924D1 (de)	2010-11-18	Brillengelenk
EP1430904A4 (fr)	2005-09-14	Desensibilisants
GB0304341D0 (en)	2003-04-02	Optical amplifier
SI1492513T1 (sl)	2007-02-28	HFA-suspenzijske formulacije, ki vsebujejo antiholinergik